Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan · Delayed Price · Currency is TWD 28.50
-0.15 (-0.52%)
Oct 30, 2026, 1:30 PM CST
TPEX:4111 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,421 | 1,376 | 1,165 | 1,061 | 1,143 | 1,022 |
Revenue Growth | 9.05% | 18.11% | 9.86% | -7.19% | 11.81% | 4.38% |
Gross Profit Gross Profit Growth | 559.75 | 543.66 | 397.18 | 343.1 | 422.51 | 356.58 |
Operating Income Operating Income Growth | 204.11 | 199.3 | 98.93 | 61.21 | 153.84 | 119.06 |
Net Income Net Income Growth | 189.07 | 164.28 | 110.63 | 68.67 | 154.01 | 80.75 |
Earnings Per Share EPS Growth | 3.13 | 2.72 | 1.84 | 1.14 | 2.56 | 1.34 |
EPS Growth | 34.64% | 47.98% | 60.83% | -55.37% | 90.77% | 36.85% |
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 1,153 | 1,050 | 1,134 | 1,014 |
Others Others Growth | 12.33 | 10.85 | 9.57 | 8.36 |
Total Total Growth | 1,165 | 1,061 | 1,143 | 1,022 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 472.29 | 443.91 | 336.19 | 381.05 | 456.25 | 252.27 |
Total Debt Total Debt Growth | 18.62 | 23.9 | 26.62 | 122.9 | 128.38 | 144 |
Net Cash (Debt) Net Cash Growth | 453.67 | 420.01 | 309.57 | 258.15 | 327.87 | 108.27 |
Net Cash Growth | 54.29% | 35.68% | 19.92% | -21.26% | 202.84% | -66.51% |
Net Cash Per Share Net Cash Per Share Growth | 7.50 | 6.95 | 5.15 | 4.30 | 5.45 | 1.80 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 306.83 | 274.61 | 213.2 | 74.52 | 214.86 | 139.33 |
Capital Expenditures CapEx Growth | -86.4 | -93.86 | -84.19 | -101.5 | -105.33 | -264.86 |
Free Cash Flow Free Cash Flow Growth | 220.43 | 180.75 | 129.01 | -26.98 | 109.53 | -125.53 |
Free Cash Flow Growth | 425.61% | 40.11% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.39% | 39.50% | 34.08% | 32.34% | 36.96% | 34.88% |
Operating Margin | 14.36% | 14.48% | 8.49% | 5.77% | 13.46% | 11.65% |
Pretax Margin | 17.09% | 15.02% | 11.82% | 8.23% | 14.20% | 12.89% |
Profit Margin | 13.30% | 11.94% | 9.49% | 6.47% | 13.47% | 7.90% |
FCF Margin | 15.51% | 13.13% | 11.07% | -2.54% | 9.58% | -12.28% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.300 | 1.300 | 0.952 | 0.952 | 1.143 | 0.952 |
Dividend Per Share Growth | 30.00% | 36.50% | 0% | -16.67% | 20.00% | 0% |
Dividend Yield | 4.56% | 4.39% | 3.60% | 3.75% | 4.43% | 4.33% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.11 | 10.73 | 14.32 | 22.11 | 10.03 | 16.30 |
Forward PE | - | 15.62 | 15.62 | 15.62 | 13.77 | 14.26 |
P/FCF Ratio | 7.74 | 9.75 | 12.28 | - | 14.10 | - |
PS Ratio | 1.20 | 1.28 | 1.36 | 1.43 | 1.35 | 1.29 |